On this page of StockholderLetter.com we present the latest annual shareholder letter from BioXcel Therapeutics, Inc. — ticker symbol BTAI. Reading current and past BTAI letters to shareholders can bring important insights into the investment thesis.
BioXcel Therapeutics, Inc. (BTAI) annual report filed on form 10k
 • shareholder letter icon 11/12/2025 Letter Continued (Full PDF)
 • Benford's Law Stocks icon BTAI Benford's Law Stock Score = 94


BTAI Shareholder/Stockholder Letter Transcript:

BioXcel Therapeutics, Inc. (BTAI) annual report filed on form 10k

shareholder letter icon 11/12/2025 Letter Continued (Full PDF)
 

BTAI Stockholder/Shareholder Letter (BioXcel Therapeutics, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.